Clinical Trials
18 trialsNCT06241235 2024-04-02
Study of ZG005 in Combination With Paclitaxel＋Platinum-based ± Bevacizumab in Patients With Advanced Cervical Carcinoma
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phase 1/2 Unknown
NCT00997009 2023-11-14
MITO CERV 2
National Cancer Institute, Naples
Phase 2 Unknown
NCT02584478 2023-11-08
AL3818
Advenchen Laboratories, LLC
Phase 3 Unknown
NCT05446883 2022-11-30
QL1706 Plus Chemotherapy±Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical Cancer
Qilu Pharmaceutical Co., Ltd.
Phase 3 Unknown
NCT04772001 2022-05-18
Concurrent Radiochemotherapy Plus Anlotinib for Locally Advanced Cervical Cancer
Zhongnan Hospital
Phase NA Unknown
NCT05151549 2021-12-09
A Study of Carilizumab Combined With Concurrent Chemoradiotherapy
Hunan Cancer Hospital
Phase 2 Unknown
NCT04974944 2021-10-01
First-line Treatment With Camrelizumab + Apatinib Versus Chemotherapy + Bevacizumab in Advanced Cervical Cancer
Sun Yat-sen University
Phase 2 Unknown
NCT04974827 2021-08-10
A Study of Camrelizumab Combined With Concurrent Chemoradiation in Patients With Cervical Cancer
Hunan Cancer Hospital
Phase 2 Unknown
NCT03912415 2020-09-18
FERMATA
Biocad
Phase 3 Unknown
NCT03912402 2019-05-09
Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy and Bevacizumab in Patients With Recurrent, Persistent or Metastatic Cervical Cancer (CAESURA)
Biocad
Phase 2 Unknown
NCT01295502 2019-03-12
Cisplatin and Radiation Therapy Followed by Paclitaxel and Carboplatin in Treating Patients With Stage IB-IVA Cervical Cancer
GOG Foundation
Phase 1 Unknown
NCT02629718 2018-03-16
SYSGO-003
Sun Yat-sen University
Phase 3 Unknown
NCT02036164 2017-04-06
ACT-LACC
Navamindradhiraj University
Phase 3 Unknown
NCT02039791 2015-08-19
Study of Nimotuzumab in Combination With Neoadjuvant Chemotherapy for Cervical Cancer
Biotech Pharmaceutical Co., Ltd.
Phase 2 Unknown
NCT02492503 2015-07-08
Effectiveness of Chemotherapy in Metastatic or Recurrent Carcinoma Cervix
All India Institute of Medical Sciences
Phase 1/2 Unknown
NCT02422563 2015-04-21
NACOPRAD
Charite University, Berlin, Germany
Phase 3 Unknown
NCT00462397 2013-08-26
Paclitaxel and Carboplatin Followed by Cisplatin and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00811408 2010-01-28
Cidofovir in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer Who Are Receiving Chemotherapy and Radiation Therapy
National Cancer Institute (NCI)
Phase 1 Unknown